Navigation Links
MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
Date:10/16/2009

WASHINGTON, Oct. 16 /PRNewswire/ -- MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference & Exhibition that add to the company's growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention.

"With influenza and RSV becoming more widespread this time of year, it remains important to better understand the impact of infectious diseases on pediatric health and the healthcare system, as well as what we can do to prevent illness," said Alexander A. Zukiwski, M.D., executive vice president and chief medical officer. "The data being presented at the conference build on our extensive foundation of research and help advance innovative solutions for preventing illnesses that negatively impact the health of children."

MedImmune abstracts to be presented at AAP on RSV include:

  • "Late Breaking Trial: A Randomized Controlled Trial of RSV Prophylaxis with Motavizumab vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease."

Feltes, T. et al., Oral Presentation; 9:30 AM - October 18, 2009; H2019 Section on Cardiology & Cardiac Surgery Program -- Washington Convention Center, Room 201

BACKGROUND: Congenital heart disease (CHD) patients are at high risk of complications from RSV lower respiratory infection and may benefit from passive immunoprophylaxis. Motavizumab is an investigational RSV-specific monoclonal antibody that is currently being evaluated for its potential to prevent serious disease caused by RSV in high-risk pediatric patients. This randomized, double-blind, active-controlled clinical trial evaluated the safety and tolerability of motavizumab in children with congenital heart disease -- a population at high risk for serious RSV disease. Secondary objectives sought
'/>"/>

SOURCE MedImmune
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
2. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
3. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
4. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
5. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
6. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
7. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
8. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
9. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
10. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
11. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ... that is developing new, patent-pending technologies poised to redefine how ... it will hold a business update teleconference and webcast for ... , 2013 at 4:30 PM ET. Fuse ... host the call and will be joined by ...
(Date:5/17/2013)... , May 17, 2013  PENTAX Medical, a ... Medical, a global leader in ultrasound imaging, recently ... companies to enable further innovation in the development ... Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic portfolio ... families of EUS systems. This agreement will continue ...
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6
... Amsterdam Molecular,Therapeutics (AMT) and Progenika Biopharma announced today ... agreement for,LPLchip(TM), a diagnostic tool to rapidly diagnose patients ... developed Glybera(R) as,a gene therapy for patients with this ... this year AMT announced new clinical data showing that ...
... , CHAPEL HILL, N.C., Oct. 29 Cempra Pharmaceuticals ... CEM-101, at the Infectious Diseases Society of America, 47th ... Philadelphia. , Susceptibility of CEM-101 and more than 25 ... pneumoniae strains collected in 2008 from medical centers ...
Cached Medicine Technology:AMT Starts Development LPLChip(TM) With Progenika 2AMT Starts Development LPLChip(TM) With Progenika 3Data Presented on Cempra Pharmaceutical's CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates 2
(Date:5/17/2013)... Spring floods, summer droughts and temperature ... who tend them. Help gardens recover from the crazy ... year. Myers suggests the following steps to revive ... by assessing the current condition of the landscape. Remove ... insect and disease organisms that can infest healthy plantings. ...
(Date:5/17/2013)... & Johnson subsidiary DePuy Orthopaedics announced on May 16 ... This comes after the company saw the market for ... increased regulation,** and after the 2010 recall of the ... a metal-on-metal hip implant law firm, applauds the decision ... that it maintains a comprehensive website at http://www.hipreplacementlawsuitcenter.com ...
(Date:5/17/2013)... Charlotte’s top professional athletes and local heroes are ... the Muscular Dystrophy Association at the annual Charlotte ... Bank of America Stadium from 6-10 p.m. , ... pairs top professional athletes and local heroes, including military ... local child living with a neuromuscular disease) for ...
(Date:5/17/2013)... Cleveland, OH (PRWEB) May 17, 2013 ... nosings are an eye-catching, resilient, slip-resistant renovation ... surface. Designed for new construction or staircase renovation ... and durability while providing a look to compliment ... industrial applications, but attractive enough for home stairs ...
(Date:5/17/2013)... -- Alcoholics who smoke have more problems with ... who are nonsmokers, researchers have found. This ... time, according to the study published online May ... Alcoholism: Clinical & Experimental Research . ... "The independent and interactive effects of smoking and ...
Breaking Medicine News(10 mins):Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 3Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 2Health News:DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP 3Health News:MDA Hosts Annual Charlotte Muscle Team Event 2Health News:MDA Hosts Annual Charlotte Muscle Team Event 3Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2Health News:Alcoholics Who Smoke May Face Early Brain Aging 2Health News:Alcoholics Who Smoke May Face Early Brain Aging 3
... statins to patients with diastolic heart failure increases// the ... drugs. ,William C. Little and his research ... with diastolic heart failure (DHF) treated with statins has ... diastolic heart failure patients published in the Journal Circulation: ...
... July 23 Prime Minister Manmohan Singh today said ... measures and coercion of any control to achieve ... first meeting of the reconstituted National Commission on ... strategy focusing on the welfare of women and ...
... Pre-eclampsia is a disease that causes high blood pressure in ... death of mother and infant in the world. Now a ... women who are likely to develop the problem. ... "We're really excited about this finding," said Clifford Librach, a ...
... can severely affect brain functions like learning and impulsive behavior.// ... latest issue of New Scientist, said that it would help ... ., ,Neuroscientists Yuriori Goto and his team at the ... stimulated the two different regions of the brain in a ...
... who are training for marathon running events may be ... from low levels of sodium in the body. The ... drink excess amounts of fluids during exercises. ,Awareness ... professionals need reliable information on the causes, recognition, prevention, ...
... Buffalo, has found that Post-menopausal// women has an increased chance ... Journal of Periodontology, which was conducted in 106 Post-menopausal women ... 57.5% of the women in the study lost at least ... loss in Post-menopausal women, as studies has proved that loss ...
Cached Medicine News:Health News:Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients 2Health News:Prime Minister Manmohan Against Incentive-Based Population Control 2Health News:Prime Minister Manmohan Against Incentive-Based Population Control 3Health News:Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child 2Health News:Regular Use Of Cocaine Can Impair Brain Functions 2Health News:Athletes Warned Of Exercise-Associated Hyponatremia 2Health News:Post-Menopausal Status May Cause Tooth Decay 2
...
... is a cutting-edge ECG management ... functionality and convenient, web-based access ... and information technology (IT) benefits, ... costs, and improved patient care. ...
... Philips' Zymed 2010 plus Holter Software ... analysis application as easy to install, ... processorwith data presentation as comprehensive as ... prospective superimposition, prospective paging and QuickScan, ...
... tiny, water-resistant monitor captures the data you ... ,Requiring only five electrodes, the DigiTrak ... the entire patient test, which can be ... AA battery. Three channels of ECG recording ...
Medicine Products: